PHA established the Corporate Committee in 2002 with a goal of fostering communication between PHA and members of the pulmonary hypertension corporate community. The committee has helped advance PHA’s mission to extend and improve the lives of those affected by PH.
Engagement, Advertising and Sponsorship
Reach the pulmonary hypertension community through our sponsored engagement services or advertising opportunities.
PHA’s sponsored engagement services offer exclusive ways to engage and involve patients, caregivers and providers:
- Industry and academic researchers can collect market and community data from people with pulmonary hypertension, caregivers and health care professionals via focus groups, interview panels, quantitative studies or advisory board participation.
- Partners can collaborate with PHA-accredited Pulmonary Hypertension Care Centers on clinical study design and clinical trial recruitment.
Engagement benefits
Offer targeted, vetted opportunities for people with pulmonary hypertension to participate in the treatment and cure of their disease.
Gather information about patients’ experience with PH, including physical and psychosocial effects; related therapies or clinical investigations; and patient preferences in line with FDA’s 2020 guidance on Patient Focused Drug Development.
Further PHA’s mission to improve and extend the lives of those affected by PH, by matching partners with willing participants to foster research and development of PH therapies.
Reach targeted audiences
PHA helps partners reach specific audiences about clinical studies or other PH projects through targeted email campaigns. You can engage patients, caregivers or health care providers, including PH Care Center directors, for clinical study collaboration.
PHA’s community database contains thousands of records, with self-reported data from people who participate in PHA events, visit PHA’s website and engage with social media channels.
Rely on comprehensive data
For precise and accurate targeting, PHA queries PHA Registry, the largest active registry of people with pulmonary hypertension. The registry contains blind data about more than 2,000 people with pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension.
Patients enroll in the registry when they begin treatment at more than 100 PHA-accredited care centers. Health care providers at the care centers regularly update the diagnostic and therapeutic data.
To reach eligible subjects, PHA will facilitate communication with patients’ clinic to confirm eligibility and recruit for studies.
To learn more information about PHA Registry services and pricing, email us. To learn more information about PHA Registry services and pricing, email us.
Learn more information about PHA Registry services and pricing.
Advertise with us
Reach the PH community and PHA members by advertising our website or in a print or digital publication.
Display your company’s message digitally on PHAssociation.org, in our flagship newsletter PHA News, our patient education newsletter PHA Connects, or our professional journal, Advances in PH. Or reach thousands of PHA members through our quarterly print magazine Pathlight.
Email us about advertising opportunities.
-
PHA Corporate Committee
-
Industry Sponsors
PHA thanks our industry sponsors who help us fulfill our mission to extend and improve the lives of people with PH.
